2023-07-012024-06-302024-06-30false11395445DATA HEALTH INTELLIGENT LIMITED2025-02-0462020falseiso4217:GBPxbrli:pure113954452023-07-01113954452024-06-30113954452023-07-012024-06-30113954452022-07-01113954452023-06-30113954452022-07-012023-06-3011395445bus:SmallEntities2023-07-012024-06-3011395445bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3011395445bus:FullAccounts2023-07-012024-06-3011395445bus:PrivateLimitedCompanyLtd2023-07-012024-06-3011395445core:WithinOneYear2024-06-3011395445core:AfterOneYear2024-06-3011395445core:WithinOneYear2023-06-3011395445core:AfterOneYear2023-06-3011395445core:ShareCapital2024-06-3011395445core:SharePremium2024-06-3011395445core:RevaluationReserve2024-06-3011395445core:OtherReservesSubtotal2024-06-3011395445core:RetainedEarningsAccumulatedLosses2024-06-3011395445core:ShareCapital2023-06-3011395445core:SharePremium2023-06-3011395445core:RevaluationReserve2023-06-3011395445core:OtherReservesSubtotal2023-06-3011395445core:RetainedEarningsAccumulatedLosses2023-06-3011395445core:LandBuildings2024-06-3011395445core:PlantMachinery2024-06-3011395445core:Vehicles2024-06-3011395445core:FurnitureFittings2024-06-3011395445core:OfficeEquipment2024-06-3011395445core:NetGoodwill2024-06-3011395445core:IntangibleAssetsOtherThanGoodwill2024-06-3011395445core:ListedExchangeTraded2024-06-3011395445core:UnlistedNon-exchangeTraded2024-06-3011395445core:LandBuildings2023-06-3011395445core:PlantMachinery2023-06-3011395445core:Vehicles2023-06-3011395445core:FurnitureFittings2023-06-3011395445core:OfficeEquipment2023-06-3011395445core:NetGoodwill2023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2023-06-3011395445core:ListedExchangeTraded2023-06-3011395445core:UnlistedNon-exchangeTraded2023-06-3011395445core:LandBuildings2023-07-012024-06-3011395445core:PlantMachinery2023-07-012024-06-3011395445core:Vehicles2023-07-012024-06-3011395445core:FurnitureFittings2023-07-012024-06-3011395445core:OfficeEquipment2023-07-012024-06-3011395445core:NetGoodwill2023-07-012024-06-3011395445core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3011395445core:ListedExchangeTraded2023-07-012024-06-3011395445core:UnlistedNon-exchangeTraded2023-07-012024-06-3011395445core:MoreThanFiveYears2023-07-012024-06-3011395445core:Non-currentFinancialInstruments2024-06-3011395445core:Non-currentFinancialInstruments2023-06-3011395445dpl:CostSales2023-07-012024-06-3011395445dpl:DistributionCosts2023-07-012024-06-3011395445core:LandBuildings2023-07-012024-06-3011395445core:PlantMachinery2023-07-012024-06-3011395445core:Vehicles2023-07-012024-06-3011395445core:FurnitureFittings2023-07-012024-06-3011395445core:OfficeEquipment2023-07-012024-06-3011395445dpl:AdministrativeExpenses2023-07-012024-06-3011395445core:NetGoodwill2023-07-012024-06-3011395445core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3011395445dpl:GroupUndertakings2023-07-012024-06-3011395445dpl:ParticipatingInterests2023-07-012024-06-3011395445dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3011395445core:ListedExchangeTraded2023-07-012024-06-3011395445dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3011395445core:UnlistedNon-exchangeTraded2023-07-012024-06-3011395445dpl:CostSales2022-07-012023-06-3011395445dpl:DistributionCosts2022-07-012023-06-3011395445core:LandBuildings2022-07-012023-06-3011395445core:PlantMachinery2022-07-012023-06-3011395445core:Vehicles2022-07-012023-06-3011395445core:FurnitureFittings2022-07-012023-06-3011395445core:OfficeEquipment2022-07-012023-06-3011395445dpl:AdministrativeExpenses2022-07-012023-06-3011395445core:NetGoodwill2022-07-012023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3011395445dpl:GroupUndertakings2022-07-012023-06-3011395445dpl:ParticipatingInterests2022-07-012023-06-3011395445dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3011395445core:ListedExchangeTraded2022-07-012023-06-3011395445dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3011395445core:UnlistedNon-exchangeTraded2022-07-012023-06-3011395445core:NetGoodwill2024-06-3011395445core:IntangibleAssetsOtherThanGoodwill2024-06-3011395445core:LandBuildings2024-06-3011395445core:PlantMachinery2024-06-3011395445core:Vehicles2024-06-3011395445core:FurnitureFittings2024-06-3011395445core:OfficeEquipment2024-06-3011395445core:AfterOneYear2024-06-3011395445core:WithinOneYear2024-06-3011395445core:ListedExchangeTraded2024-06-3011395445core:UnlistedNon-exchangeTraded2024-06-3011395445core:ShareCapital2024-06-3011395445core:SharePremium2024-06-3011395445core:RevaluationReserve2024-06-3011395445core:OtherReservesSubtotal2024-06-3011395445core:RetainedEarningsAccumulatedLosses2024-06-3011395445core:NetGoodwill2023-06-3011395445core:IntangibleAssetsOtherThanGoodwill2023-06-3011395445core:LandBuildings2023-06-3011395445core:PlantMachinery2023-06-3011395445core:Vehicles2023-06-3011395445core:FurnitureFittings2023-06-3011395445core:OfficeEquipment2023-06-3011395445core:AfterOneYear2023-06-3011395445core:WithinOneYear2023-06-3011395445core:ListedExchangeTraded2023-06-3011395445core:UnlistedNon-exchangeTraded2023-06-3011395445core:ShareCapital2023-06-3011395445core:SharePremium2023-06-3011395445core:RevaluationReserve2023-06-3011395445core:OtherReservesSubtotal2023-06-3011395445core:RetainedEarningsAccumulatedLosses2023-06-3011395445core:NetGoodwill2022-07-0111395445core:IntangibleAssetsOtherThanGoodwill2022-07-0111395445core:LandBuildings2022-07-0111395445core:PlantMachinery2022-07-0111395445core:Vehicles2022-07-0111395445core:FurnitureFittings2022-07-0111395445core:OfficeEquipment2022-07-0111395445core:AfterOneYear2022-07-0111395445core:WithinOneYear2022-07-0111395445core:ListedExchangeTraded2022-07-0111395445core:UnlistedNon-exchangeTraded2022-07-0111395445core:ShareCapital2022-07-0111395445core:SharePremium2022-07-0111395445core:RevaluationReserve2022-07-0111395445core:OtherReservesSubtotal2022-07-0111395445core:RetainedEarningsAccumulatedLosses2022-07-0111395445core:AfterOneYear2023-07-012024-06-3011395445core:WithinOneYear2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3011395445core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3011395445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3011395445core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3011395445core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3011395445core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3011395445bus:Director12023-07-012024-06-30

DATA HEALTH INTELLIGENT LIMITED

Registered Number
11395445
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

DATA HEALTH INTELLIGENT LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Director

XU, Fenglian, Dr

Registered Address

C/O Xeinadin First Floor Secure House
Lulworth Close
Chandler's Ford
SO53 3TL

Registered Number

11395445 (England and Wales)
DATA HEALTH INTELLIGENT LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets31,9043,305
1,9043,305
Current assets
Debtors1,064937
Cash at bank and on hand1,6544,403
2,7185,340
Creditors amounts falling due within one year4(39,564)(28,772)
Net current assets (liabilities)(36,846)(23,432)
Total assets less current liabilities(34,942)(20,127)
Net assets(34,942)(20,127)
Capital and reserves
Called up share capital1,0001,000
Profit and loss account(35,942)(21,127)
Shareholders' funds(34,942)(20,127)
The financial statements were approved and authorised for issue by the Director on 4 February 2025, and are signed on its behalf by:
XU, Fenglian, Dr
Director
Registered Company No. 11395445
DATA HEALTH INTELLIGENT LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
Assurances have been obtained from the directors that the company will continue to operate in the foreseeable future and will be able to meets its liabilities as and when they fall due.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 July 235,6035,603
At 30 June 245,6035,603
Depreciation and impairment
At 01 July 232,2982,298
Charge for year1,4011,401
At 30 June 243,6993,699
Net book value
At 30 June 241,9041,904
At 30 June 233,3053,305
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables-10
Amounts owed to related parties38,66427,947
Accrued liabilities and deferred income900815
Total39,56428,772
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Related party transactions
As of the 30th June 2024, the following amounts are owed to Mrs F Xu - £38,663.58